Total Funding
87
88
Total FundingCorporate Round raised
Growth Score
-2 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81343
SML Biopharm develops mRNA-based vaccines and therapeutics focused on cancer immunotherapy, infectious diseases, and research solutions.
Yong-Kwan Kim: CEO
About the Company
SML Biopharm is a biotechnology company specializing in mRNA-based vaccines and therapeutics for cancer immunotherapy and infectious diseases. The company conducts research in advanced drug development and biomedical technologies to support innovative treatment approaches. Through its R&D capabilities, SML Biopharm aims to expand the
application of mRNA technologies in the global healthcare industry.
